New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
07:03 EDTACORAcorda names Andrew Hindman as Chief Business Development Officer
Acorda Therapeutics has appointed Andrew Hindman as Chief Business Development Officer. Hindman has held several senior executive level positions in the biopharmaceutical industry, most recently as President, CEO and member of the Board of Tobira Therapeutics, a privately-held biotechnology company.
News For ACOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
07:08 EDTACORAcorda Therapeutics announces initiation of Phase 3 dalfampridine trial
Subscribe for More Information
December 10, 2014
07:02 EDTACORAcorda Therapeutics announces initiation of Phase 3 CVT-301 trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use